Lung cancer staging: Pathology issues

Seminars in Diagnostic Pathology

Volumn 29, Issue 3, 2012, Pages 116-126

  Sica, Gabriel L ^a   Gal, Anthony A ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Lung cancer; Staging; TNM

Indexed keywords

MUCIN;

ADAPTATION; ARTICLE; ATELECTASIS; BRONCHUS CARCINOID; CANCER CLASSIFICATION; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC BIOPSY; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; METASTASIS; PLEURA; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC;

EID: 84867441744     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.06.001     Document Type: Article

References (67)

1. Mountain C.F., Carr D.T., Anderson W.A. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med 1974, 120:130-138.
2. Goldstraw P. International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology 2009, Editorial Rx Press, Orange Park, FL.
3. Pao W., Iafrate A.J., Su Z. Genetically informed lung cancer medicine. J Pathol 2011, 223:230-240.
4. McLoud T.C. "A system for the clinical staging of lung cancer"-a commentary. AJR Am J Roentgenol 2006, 187:269-270.
5. Langer C.J., Besse B., Gualberto A., et al. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 2010, 28:5311-5320.
6. Postmus P.E., Brambilla E., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007, 2:686-693.
7. Goldstraw P., Crowley J., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
8. Rami-Porta R., Ball D., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
9. Rusch V.W., Crowley J., Giroux D.J., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:603-612.
10. Rusch V.W., Asamura H., Watanabe H., et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577.
11. Groome P.A., Bolejack V., Crowley J.J., et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705.
12. Shepherd F.A., Crowley J., Van Houtte P., et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
13. Travis W.D., Brambilla E., Noguchi M., et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
14. Travis W.D., Brambilla E., Rami-Porta R., et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3:1384-1390.
15. Travis W.D., Giroux D.J., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for the inclusion of Broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3:1213-1223.
16. Vallières E., Shepherd F.A., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:1049-1059.
17. Butnor K.J., Beasley M.B., Cagle P.T., et al. Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. Arch Pathol Lab Med 2009, 133:1552-1559.
18. Blasberg J.D., Pass H.I., Donington J.S. Sublobar resection: a movement from the lung cancer Study Group. J Thorac Oncol 2010, 5:1583-1593.
19. Asamura H., Suzuki K., Watanabe S., et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003, 76:1016-1022.
20. Flieder D.B., Port J.L., Korst R.J., et al. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest 2005, 128:2304-2308.
21. Ou S.H., Zell J.A., Ziogas A., et al. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest 2008, 133:662-669.
22. Giroux D.J., Rami-Porta R., Chansky K., et al. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J Thorac Oncol 2009, 4:679-683.
23. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004, 78:1200-1205. discussion 1206.
24. Stupp R., Mayer M., Kann R., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol 2009, 10:785-793.
25. Hehr T., Friedel G., Steger V., et al. Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected stage III non-small-cell lung cancer: long-term results of a trimodality phase II protocol. Int J Radiat Oncol Biol Phys 2010, 76:1376-1381.
26. Torre W., Garcia-Franco C., Tamura A., et al. Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): morbidity and prognostic factors for long-term success after resection. J Thorac Cardiovasc Surg 2009, 57:353-357.
27. Rusch V.W. Management of Pancoast tumours. Lancet Oncol 2006, 7:997-1005.
28. Junker K., Langner K., Klinke F., et al. Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 2001, 120:1584-1591.
29. Junker K., Thomas M., Schulmann K., et al. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 1997, 123:469-477.
30. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004, IARC, Lyon, France. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink (Eds.).
31. Kennedy T.C., McWilliams A., Edell E., et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:221S-233S.
32. Noguchi M., Morikawa A., Kawasaki M., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.
33. Watanabe S., Watanabe T., Arai K., et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002, 73:1071-1075.
34. Vazquez M., Carter D., Brambilla E., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009, 64:148-154.
35. Yoshizawa A., Motoi N., Riely G.J., et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011, 24:653-664.
36. Sica G., Yoshizawa A., Sima C.S., et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010, 34:1155-1162.
37. Barletta J.A., Yeap B.Y., Chirieac L.R. Prognostic significance of grading in lung adenocarcinoma. Cancer 2010, 116:659-669.
38. Motoi N., Szoke J., Riely G.J., et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008, 32:810-827.
39. Kamiya K., Hayashi Y., Douguchi J., et al. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol 2008, 21:992-1001.
40. Miyoshi T., Satoh Y., Okumura S., et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003, 27:101-109.
41. Amin M.B., Tamboli P., Merchant S.H., et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002, 26:358-364.
42. Travis W.D. Reporting lung cancer pathology specimens. Impact of the anticipated 7th edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 2009, 54:3-11. IASLC Staging Committee.
43. Hsu P.K., Huang H.C., Hsieh C.C., et al. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg 2007, 84:1825-1829.
44. Van Schil P.E., Asamura H., Rusch V.W., et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2012, 39:478-486.
45. Travis W.D., Garg K., Franklin W.A., et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005, 23:3279-3287.
46. Gemma A., Noguchi M., Hirohashi S., et al. Clinicopathologic and immunohistochemical characteristics of goblet cell type adenocarcinoma of the lung. Acta Pathol Jpn 1991, 41:737-743.
47. Flieder D.B. Commonly encountered difficulties in pathologic staging of lung cancer. Arch Pathol Lab Med 2007, 131:1016-1026.
48. Yoshida J., Nagai K., Asamura H., et al. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol 2009, 4:959-963.
49. Kang J.H., Kim K.D., Chung K.Y. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg 2003, 23:865-869.
50. Shimizu K., Yoshida J., Nagai K., et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005, 130:160-165.
51. Kawase A., Yoshida J., Ishii G., et al. Visceral pleural invasion classification in non-small cell lung cancer. J Thorac Oncol 2010, 5:1784-1788.
52. Shimizu K., Yoshida J., Nagai K., et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg 2004, 127:1574-1578.
53. Butnor K.J., Vollmer R.T., Blaszyk H., et al. Interobserver agreement on what constitutes visceral pleural invasion by non-small cell lung carcinoma: an internet-based assessment of international current practices. Am J Clin Pathol 2007, 128:638-647.
54. Carter C., Lawrence T., Otis C.N. Serous membranes, in Histology for Pathologists 1997, Lippincott-Raven Publishers, Philadelphia, PA. (ed 2).
55. Hammar S.P. Common tumors, in Pulmonary Pathology 1994, Springer-Verlag, New York, NY. (ed 2).
56. Bunker M.L., Raab S.S., Landreneau R.J., et al. The diagnosis and significance of visceral pleural invasion in lung carcinoma. Histologic predictors and the role of elastic stains. Am J Clin Pathol 1999, 112:777-783.
57. Nonaka M., Kataoka D., Yamamoto S., et al. Outcome following surgery for primary lung cancer with interlobar pleural invasion. Surg Today 2005, 35:22-27.
58. Okada M., Tsubota N., Yoshimura M., et al. How should interlobar pleural invasion be classified?. Prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 1999, 68:2049-2052.
59. Miura H., Taira O., Uchida O., et al. Invasion beyond interlobar pleura in non-small cell lung cancer. Chest 1998, 114:1301-1304.
60. Sakai Y., Ohbayashi C., Kanomata N., et al. Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancer. Lung Cancer 2011, 73:89-95.
61. Finley D.J., Yoshizawa A., Travis W., et al. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol 2010, 5:197-205.
62. Girard N., Deshpande C., Azzoli C.G., et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest 2010, 137:46-52.
63. Girard N., Deshpande C., Lau C., et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009, 33:1752-1764.
64. Martini N., Melamed M.R. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975, 70:606-612.
65. Marchevsky A.M., Gupta R., Kusuanco D., et al. The presence of isolated tumor cells and micrometastases in the intrathoracic lymph nodes of patients with lung cancer is not associated with decreased survival. Hum Pathol 2010, 41:1536-1543.
66. Rusch V.W., Hawes D., Decker P.A., et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 2011, 29:4313-4319.
67. Ignatius Ou S.H., Zell J.A. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM edition. J Thorac Oncol 2009, 4:300-310.